Balbus, John M., Andrew D. Maynard, and Vicki L. Colvin. “Meeting Report: Hazard Assessment for Nanoparticles - Report from an Interdisciplinary Workshop.” Environmental Health Perspectives 115.11 (2007): 1654-659.
Biswas, Pratim and Chang-Yu Wu, “Nanoparticles and the environment - A Critical Review Paper.” J. Air and Waste Mgmt. Association 55 (2005): 708-746.
Dobrovolskaia, Marina A., Parag Aggarwal, Jennifer B. Hall, and Scott E. McNeil. “Preclinical Studies to Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution.” Molecular Pharmaceutics (2008).
Drezek, Rebekah, and Tour M. James. “Is Nanotechnology Too Broad to Practise?” Nature Nanotechnology 5 (2010): 168-69.
Grainger, David, and Clinton F. Jones. “In Vitro Assessment of Nanomaterial Toxicity.” Advanced Drug Delivery Reviews 61 (2009): 438-56.
Grainger, David, and Clinton F. Jones. “Preface: Nanotoxicity Assessment: All Small Talk?” Advanced Drug Delivery Reviews 61 (2009): 419-21.
Grainger, David, and David G. Castner. “Nanomaterials and Nanoanalysis: Opportunities for Improving the Science to Benefit Biomedical Technologies.” Advanced Materials (2008): 867-77.
Jain, Tapan K., Maram K. Reddy, Marco A. Morales, Diandra L. Leslie-Pelecky, and Vinod Labhasetwar. “Biodistribution, Clearance, and Biocompatibililty of Iron Oxide Magnetic Nanoparticles in Rats.” Molecular Pharmaceutics 5.2 (2008): 316-327.
Jiang J., Günter Oberdörster, Alison Elder, R. Gelein, P. Mercer, and Pratim Biswas. “Does Nanoparticle Toxicity Depend on Size and Crystal Phase?” Nanotoxicology 2.1 (2008): 33-42.
Li, Shyh-Dar and Leaf Huang. “Pharmacokinetics and Biodistribution of Nanoparticles.” Molecular Pharmaceutics 5 (2008): 496–504.
Nordmann, Alfred. “Beyond Regulation?” Nano Magazine 14 (2009): 29-31.
Nordmann, Alfred. “Philosophy of Technoscience in the Regime of Vigilance.” Ed. Diana Bowman, Graeme Hodge, and Andrew Maynard. International Handbook on Regulating Nanotechnologies (2010).
Oberdörster, Günter, Alison Elder, and Amber Rinderknecht. “Nanoparticles and the Brain: Cause for Concern?” Journal of Nanoscience and Technology 9 (2009): 4996-5007.
Oberdörster, Günter, Jan Oberdörster, and Eva Oberdörster. “Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles.” Environmental Health Perspectives 113.7 (2005): 823-39.
Oberdörster, Günter, Vicki Stone, and Ken Donaldson. “Toxicology of Nanoparticles: A Historical Perspective.” Nanotoxicology 1.1 (2007): 2-25.
Preston, Christopher, Maxim Y. Sheinin, Denyse J. Sproat, and Vimal P. Swarup. “The Novelty of Nano and the Regulatory Challenge of Newness.” Nanoethics (2010).
Ruenraroengsak, Pakatip, Janice M. Cook, and Alexander T. Florence. “Nanosystem drug targeting: Facing up to complex realities.” Journal of Controlled Release 141 (2010): 265–276.
Sargent, John Jr. "Nanotechnology: A Policy Primer." Congressional Research Service (2010)
Satterfield, Terre, Milind Kandlikar, Christian E.H. Beaudrie, Joseph Conti and Barbara Herr Hawthorn. “Anticipating the perceived risk of nanotechnologies.” Nature Nanotechnology (2009): 1-7.
Shvedova, Anna A., Valerian E. Kagan, and Bengt Fadeel. “Close Encounters of the Small Kind: Adverse Effects of Man-Made Materials Interfacing with the Nano-Cosmos of Biological Systems.” Annual Review of Pharmacology and Toxicology 50 (2010): 63–88.
U.S. Food and Drug Administration. "Nanotechnology Task Force Report." (2007).
Yan, B., B.A. Wrenn, S. Basak, Pratim Biswas, and D.E. Giammar. “Microbial Reduction of Fe(III) in Hematite Nanoparticles by Geobacter Sulfurreducens.” Environmental Science and Technology 42.17 (2008): 6226-6231.